Injection drug users' experience with and attitudes toward methadone clinics in Denver, CO

Journal of Substance Abuse Treatment

Volumn 41, Issue 1, 2011, Pages 30-36

  Al Tayyib, Alia A ^a,b   Koester, Stephen ^c  

^a DENVER PUBLIC HEALTH   (United States)

^b Global Health and Health Disparities   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Clients' perceptions; Hepatitis C; HIV; Methadone

Indexed keywords

METHADONE;

ADULT; ARTICLE; FEMALE; HEALTH CARE FACILITY; HEPATITIS C; HEROIN DEPENDENCE; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; PATIENT ATTITUDE; PATIENT COUNSELING; PRIORITY JOURNAL; UNITED STATES;

ADULT; ATTITUDE; COLORADO; CROSS-SECTIONAL STUDIES; FEMALE; HEROIN DEPENDENCE; HUMANS; MALE; METHADONE; MIDDLE AGED; ROC CURVE; SUBSTANCE ABUSE, INTRAVENOUS; TREATMENT OUTCOME;

EID: 79957978242     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2011.01.009     Document Type: Article

References (36)

1. Appel P.W., Joseph H., Richman B.L. Causes and rates of death among methadone maintenance patients before and after the onset of the HIV/AIDS epidemic. The Mount Sinai Journal of Medicine 2000, 67(5-6):444-451.
2. Bourgois P. Disciplining addictions: The bio-politics of methadone and heroin in the United States. Culture, Medicine and Psychiatry 2000, 24(2):165-195.
3. Bourgois P., Schoenberg J. Righteous dope fiend 2009, University of California Press, Berkeley.
4. Carlson R.G. Ethnography and applied substance use research: Anthropological and cross-cultural factors. Rethinking substance abuse: What science shows and what we should do about it 2006, Guilford Publications, New York. W.M.A.K. Carroll (Ed.).
5. CDC HIV prevalence, unrecognized infection, and HIV testing among men who have sex with men-Five U.S. cities, June 2004-April 2005. MMWR. Morbidity and Mortality Weekly Report 2005, 54(24):597-601.
6. CDC HIV-associated behaviors among injecting-drug users-23 cities, United States, May 2005-February 2006. MMWR. Morbidity and Mortality Weekly Report 2009, 58(13):329-332.
7. Clausen T., Anchersen K., Waal H. Mortality prior to, during and after opioid maintenance treatment (OMT): A national prospective cross-registry study. Drug Alcohol Depend 2008, 94(1-3):151-157.
8. Corsi K.F., Lehman W.K., Booth R.E. The effect of methadone maintenance on positive outcomes for opiate injection drug users. Journal of Substance Abuse Treatment 2009, 37(2):120-126.
9. Deren S., Goldstein M.F., Des Jarlais D.C., Richman B.L., Kang S., Flom P.L. Drug use, HIV-related risk behaviors and dropout status of new admissions and re-admissions to methadone treatment. Journal Of Substance Abuse Treatment 2001, 20(2):185-189.
10. Effective medical treatment of opiate addiction.National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction Journal of the American Medical Association 1998, 280(22):1936-1943.
11. Fischer B., Chin A.T., Kuo I., Kirst M., Vlahov D. Canadian illicit opiate users' views on methadone and other opiate prescription treatment: An exploratory qualitative study. Substance Use & Misuse 2002, 37(4):495-522.
12. Gallagher K.M., Sullivan P.S., Lansky A., Onorato I.M. Behavioral surveillance among people at risk for HIV infection in the U.S.: The National HIV Behavioral Surveillance System. Public Health Reports 2007, 122(Suppl 1):32-38.
13. Gottheil E., Sterling R.C., Weinstein S.P. Diminished illicit drug use as a consequence of long-term methadone maintenance. Journal Of Addictive Diseases: the Official Journal of the ASAM, American Society of Addiction Medicine 1993, 12(4):45-57.
14. Gwin Mitchell S., Kelly S.M., Brown B.S., Schacht Reisinger H., Peterson J.A., Ruhf A., et al. Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland. The American Journal on Addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2009, 18(5):346-355.
15. Harrell F. Regression modeling strategies: With applications to linear models, logistic regression, and survival analysis 2001, Springer-Verlag., New York, NY.
16. Kleber H.D. Methadone maintenance 4 decades later: Thousands of lives saved but still controversial. Jama 2008, 300(19):2303-2305.
17. Koester S., Anderson K., Hoffer L. Active heroin injectors' perceptions and use of methadone maintenance treatment: Cynical performance or self-prescribed risk reduction?. Substance Use & Misuse 1999, 34(14):2135-2153.
18. Kwiatkowski C.F., Booth R.E. Methadone maintenance as HIV risk reduction with street-recruited injecting drug users. Journal of Acquired Immune Deficiency Syndromes 2001, 26(5):483-489.
19. Langendam M.W., van Brussel G.H., Coutinho R.A., van Ameijden E.J. The impact of harm-reduction-based methadone treatment on mortality among heroin users. American Journal of Public Health 2001, 91(5):774-780.
20. Lansky A., Abdul-Quader A.S., Cribbin M., Hall T., Finlayson T.J., Garfein R.S., et al. Developing an HIV behavioral surveillance system for injecting drug users: The National HIV Behavioral Surveillance System. Public Health Reports 2007, 122(Suppl 1):48-55.
21. Laudet A.B., Stanick V., Sands B. What could the program have done differently? A qualitative examination of reasons for leaving outpatient treatment. Journal of Substance Abuse Treatment 2009, 37(2):182-190.
22. MacKellar D.A., Gallagher K.M., Finlayson T., Sanchez T., Lansky A., Sullivan P.S. Surveillance of HIV risk and prevention behaviors of men who have sex with men-A national application of venue-based, time-space sampling. Public Health Reports 2007, 122)(Suppl 1):39-47.
23. Marsch L.A. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: A meta-analysis. Addiction 1998, 93(4):515-532.
24. Mattick R.P., Ali R., White J.M., O'Brien S., Wolk S., Danz C. Buprenorphine versus methadone maintenance therapy: A randomized double-blind trial with 405 opioid-dependent patients. Addiction 2003, 98(4):441-452.
25. Mattick R.P., Breen C., Kimber J., Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews 2003, (2):CD002209.
26. Metzger D.S., Woody G.E., McLellan A.T., O'Brien C.P., Druley P., Navaline H., et al. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: An 18-month prospective follow-up. Journal of Acquired Immune Deficiency Syndromes 1993, 6(9):1049-1056.
27. Neale J. Understanding drug using clients' views of substitute prescribing. British Journal of Social Work 1999, 29:127-145.
28. Peterson J.A., Schwartz R.P., Mitchell S.G., Reisinger H.S., Kelly S.M., O'Grady K.E., et al. Why don't out-of-treatment individuals enter methadone treatment programmes?. The International Journal on Drug Policy 2010, 21(1):36-42.
29. Reisinger H.S., Schwartz R.P., Mitchell S.G., Peterson J.A., Kelly S.M., O'Grady K.E., et al. Premature discharge from methadone treatment: Patient perspectives. Journal of Psychoactive Drugs 2009, 41(3):285-296.
30. Rosen D. Factors associated with illegal drug use among older methadone clients. Gerontologist 2004, 44(4):543-547.
31. Selvin S. Analysis of contingency table data, logistic models. Statistical analysis of epidemiologic data 2004, Oxford Press., New York, N. 3rd ed.
32. Simpson D.D., Joe G.W., Rowan-Szal G.A., Greener J.M. Drug abuse treatment process components that improve retention. Journal of Substance Abuse Treatment 1997, 14(6):565-572.
33. Stancliff S., Myers J.E., Steiner S., Drucker E. Beliefs about methadone in an inner-city methadone clinic. Journal Of Urban Health: Bulletin of the New York Academy of Medicine 2002, 79(4):571-578.
34. Thiede H., Hagan H., Murrill C.S. Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area. Journal of Urban Health: Bulletin of the New York Academy of Medicine 2000, 77(3):331-345.
35. Willner-Reid J., Belendiuk K.A., Epstein D.H., Schmittner J., Preston K.L. Hepatitis C and human immunodeficiency virus risk behaviors in polydrug users on methadone maintenance. Journal of Substance Abuse Treatment 2008, 35(1):78-86.
36. Zaller N.D., Bazazi A.R., Velazquez L., Rich J.D. Attitudes toward methadone among out-of-treatment minority injection drug users: Implications for health disparities. International Journal of Environmental Research and Public Health 2009, 6(2):787-797.